Jane D. Englebright

Jane D. Englebright, listed as senior executive, appears in our data through filings on HCA Healthcare, Inc. shares, published by SEC (Form 4). The record holds 12 filings, for trades running from 2 February 2016 to 9 November 2021.

No open-market purchase appears, only 3 sales worth €2.2M. Other entries cover 3 share grants and 5 option exercises. So far in 2021, the count stands at no purchases and 3 sales.

The latest filing, published on 12 November 2021, reports an open-market sale of €724k in HCA Healthcare, Inc. Filings reach the SEC (Form 4) feed a median of 3 days after the trade. Section 16 rules allow two business days to file each Form 4. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.